3 Key Trends to Consider for Oncology Management by Rebecca Borgert June 5, 2019Cancer, Cancer treatment, FDA, Magellan, Magellan Health, Magellan Healthcare, Magellan RX, Magellan Rx Management, Medical Benefit Drug Management, Medical Oncology Spend, Novel Cancer Drugs, Oncology, Oncology Biosimilars, Oncology Management
Trend Alert: FDA Approvals – A Year in Review by Lara Frick March 22, 2019Biosimilars, FDA, FDA Approvals, Magellan, Magellan Health, Magellan Healthcare, Magellan RX, Magellan Rx Management, New Drug Therapy Approvals, Novel drugs, Orphan Drugs, Rare Diseases
MRx Pipeline by Maryam Tabatabai November 30, 2018Biosimilars, Drug Pipeline, Emerging therapeutics, FDA, Magellan, Magellan Health, Magellan RX, Magellan Rx Management, MRx Pipeline, Orphan Drugs, Specialty Medications
